Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
The optimal timing of AC initiation is ∼37 days after concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. A delay beyond 69.5 days is associated with compromised survival. Efforts should be made to address the reasons for delays and ensure the timely initiation of AC.
Authors
- Guodong Jia (ORCID: https://orcid.org/0000-0002-8360-0460)
- Liangrong Liu (ORCID: https://orcid.org/0009-0001-3533-9026)
- Hai‐Qiang Mai (ORCID: https://orcid.org/0000-0002-9035-6814)
- Jie‐Yi Lin (ORCID: https://orcid.org/0009-0007-7410-2308)
- Jie Chen (ORCID: https://orcid.org/0000-0002-2658-9525)
- Qing Chen (ORCID: https://orcid.org/0000-0002-8392-0552)
- Yang Li (ORCID: https://orcid.org/0000-0001-9612-2704)
- Yong Chen (ORCID: https://orcid.org/0000-0002-3891-2721)
- Yuanbo Liang (ORCID: https://orcid.org/0000-0001-9685-7356)
- H. Cheng (ORCID: https://orcid.org/0000-0003-3314-8311)
- Liang Tang (ORCID: https://orcid.org/0000-0003-0446-143X)
- Peng Wang (ORCID: https://orcid.org/0000-0002-5716-9937)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- ESMO Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.esmoop.2024.103707
- Citations
- 3
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.74
Funders
- National Natural Science Foundation of China
- Sun Yat-sen University
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- Basic and Applied Basic Research Foundation of Guangdong Province